Skip to main content
The Globe and Mail
Get full access to globeandmail.com
Support quality journalism
Just $1.99 per week for the first 24weeks
Just $1.99 per week for the first 24weeks
The Globe and Mail
Support quality journalism
Get full access to globeandmail.com
Globe and Mail website displayed on various devices
Just$1.99
per week
for the first 24weeks

var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){console.log("scroll");var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))}pencilInit(".js-sub-pencil",!1);
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 5.50
Day High 6.15
Open:6.14
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Tilray, Inc. is a pharmaceutical company. It develops cannabis based medicines, drugs, drops and oil products. Tilray, Inc. is based in NANAIMO, Canada.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ALGN, TLRY, XP INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
- GlobeNewswire - Fri Apr 3, 9:50PM CDT
GlobeNewswire - CMTX
Fri Apr 3, 9:50PM CDT
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits:
ROSEN, A TOP RANKED LAW FIRM, Reminds Tilray, Inc. Investors of Important Deadline in Securities Class Action Lawsuit - TLRY
- GlobeNewswire - Fri Apr 3, 2:00PM CDT
GlobeNewswire - CMTX
Fri Apr 3, 2:00PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Tilray, Inc. (NASDAQ: TLRY) between January 15, 2019 and March 2, 2020, inclusive (the "Class Period"), of the important May 5, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Tilray investors under the federal securities laws.
Thinking about buying stock in Biomerica, Co-Diagnostics, Ford, Overstock.com, or Tilray?
- PR Newswire - Thu Apr 2, 8:31AM CDT
PR Newswire - CMTX
Thu Apr 2, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for BMRA, CODX, F, OSTK, and TLRY.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 2.43 +127.98% increase
on 03/18/20
Period Open:13.02
Price movement based on the high, low and last over the given period.
13.45 -58.81% decrease
on 03/04/20
-7.48 (-57.45%) decrease
since 03/03/20
3-Month 2.43 +127.98% increase
on 03/18/20
Period Open:16.01
Price movement based on the high, low and last over the given period.
22.95 -75.86% decrease
on 01/21/20
-10.47 (-65.40%) decrease
since 01/03/20
52-Week 2.43 +127.98% increase
on 03/18/20
Period Open:63.38
Price movement based on the high, low and last over the given period.
63.62 -91.29% decrease
on 04/04/19
-57.84 (-91.26%) decrease
since 04/03/19

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2020.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies